/
Medicinal chemicals & botanical products company · NV · FY ends Dec · Revenue $5M · -22.42% margin · $211K FCF
The business is unprofitable at the operating level (-20.92% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 44.9%, still solid. Margins contracted 15.0pp, which offsets some of the top-line progress.
Free cash flow declined 41% versus the prior year, cash generation momentum has weakened. Net debt of $2M represents 9.8x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
$5M
▲ +44.9% YoY
Net Income (TTM)
-$683K
▼ -4.8% YoY
Op. Margin
-22.42%
▼ -15.0pp YoY
ROIC
-4.78%
▲ +10.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$211K
▼ -41.3% YoY
Op. Cash Flow (TTM)
$211K
▼ -41.3% YoY
Net Debt
$2M
Cash & Equiv.
$164K
5Y CAGR: +28.7%
5Y CAGR: -38.6%
Continue Research